NEIL3 and prostate carcinoma: Specifically, NEIL3 SNPs were associated with the risk of glioma, prostate, and thyroid cancer [47,48,49], with rs7689099 being associated with a reduced risk of differentiated thyroid carcinoma and prostate cancer [47,49].